CLINICAL_TRIALS
trial_result
· 2022-04-13
Clinical Trial Update: Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden [Phase 4]
Summary
Phase 4 trial results evaluating the efficacy of AJOVY (fremanezumab-vfrm) on interictal migraine-related burden have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David True | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2022-04-13